David Efraim Rosen, 10% Owner of Heron Therapeutics HRTX, has filed 1 purchase and 24 sales on the open market. The latest trade was on 25/10/15.

DR

DR

David Efraim Rosen

10% Owner

Company

Heron Therapeutics HRTX

First filing

23/01/03

Trades

35 trades

Buys / sales

1 / 24

12-month net buying

No record

Last trade

25/10/15

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Collegium PharmaceuticalCOLL	Open-market sale	25/08/13	25/08/15	25,000 sh	$37.85	$946,250	−0.8%
Heron TherapeuticsHRTX	Open-market buy	25/08/08	25/08/12	2,387,225 sh	$1.50	$3,580,837.5	+8.9%
Talen EnergyTLN	Open-market sale	25/06/25–25/06/27	25/06/27	388,530 sh21 trades	$293.65avg.	$114,092,238.77	−6.3%
Talen EnergyTLN	Open-market sale	24/12/13	24/12/16	4,893,507 sh	$204.35	$999,988,155.45	−43.0%
TherapeuticsMDTXMD	Open-market sale	22/12/30	23/01/03	29,000 sh	$1,333.00	$38,657,000	−100.0%